openPR Logo
Press release

Companion Diagnostics Market: Full In-depth Analysis by Regional Outlook, Business Growth and Opportunities, Top Players like Roche, QIAGEN, Abbott, Agilent Technologies, Ventana Medical Systems Inc., Myriad Genetics, Leica Biosystems and others

10-18-2018 09:31 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Companion Diagnostics Market

Global Companion Diagnostics Market

Global Companion Diagnostics Market research report is a meticulous investigation of current scenario of the market, which covers several market dynamics. The report is a comprehensive statistical analysis of the Global Companion Diagnostics Market's continuous positive developments, capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

The Global Companion Diagnostics Market report also contains the drivers and restrains for the market that are derived from SOWT analysis, and also shows what all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market are by systemic company profiles.

The Global Companion Diagnostics Market accounted to USD 9.40 billion in 2024, growing at a CAGR of 19.8% during the forecast period of 2017 to 2024.

For In depth Information Get Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-companion-diagnostics-market

Complete report on Global Companion Diagnostics Market Research Report 2017-2024 spread across 350 Pages, profiling Top companies and supports with tables and figures

Market Definition: Global Companion Diagnostics Market

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic treatment of patients through which they can be benefitted from certain drug dosage according to their diagnosis, allergies and necessity. Here much technological advancement has been made in order to improve this along with the growing requirements for enhanced personalized patient treatment so that complete assurance must be given by the doctors.

Top Key Players:

• F. Hoffmann La Roche Diagnostics,
• QIAGEN ,
• Abbott,
• Agilent Technologies,
• Ventana Medical Systems Inc.,
• Myriad Genetics,
• Leica Biosystems Nussloch GmbH,
• RESONANCE HEALTH,
• ARUP Laboratories,
• Life Technologies,
• Thermo Fisher Scientific Inc.,
• BioMerieux SA

Major market drivers & restraints:

• Increasing number of genetic testing
• Growing technological development
• Increase in cost related to technological advancement

Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-companion-diagnostics-market

Core Objectives of Companion Diagnostics Market research

• To identify key players operating in the Companion Diagnostics market and comprehensively analyze their market rankings and core competencies.

• To describe major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Companion Diagnostics Market and submarkets.

• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Market Segmentations:

On the basis of product and services, global companion diagnostics market is segmented into

• Assay kits and reagents
• Software & services.

On the basis of technology, global companion diagnostics market is segmented into

• Polymerase chain reaction,
• Immunohistochemistry,
• Next-generation sequencing
• In situ hybridization.

On the basis of indication, global companion diagnostics market is segmented into

• Oncology,
• Neurology and infectious diseases

Oncology is sub segmented into breast cancer, lung cancer, colorectal cancer, gastric cancer and melanoma.

On the basis of end users global companion diagnostics market is segmented into

• Pharmaceutical
• Biopharmaceutical companies
• Reference laboratories.

On the basis of geography

• North America
• South America,
• Europe,
• Asia-Pacific,
• Middle East & Africa.

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis: Global Companion Diagnostics Market

The global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes companion diagnostics shares for global, Europe, North America, Asia Pacific, and South America.

For more insightful information visit @ https://databridgemarketresearch.com/reports/global-companion-diagnostics-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market: Full In-depth Analysis by Regional Outlook, Business Growth and Opportunities, Top Players like Roche, QIAGEN, Abbott, Agilent Technologies, Ventana Medical Systems Inc., Myriad Genetics, Leica Biosystems and others here

News-ID: 1313880 • Views:

More Releases from Data Bridge Market Research

Intravascular Warming Systems Market Size, Share, Trends, Demand, Industry Growth and Competitive Outlook
Intravascular Warming Systems Market Size, Share, Trends, Demand, Industry Growt …
Global Intravascular Warming Systems Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Intravascular Warming Systems market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the world. By keeping in
Matte Films Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Matte Films Market Size, Share, Trends, Key Drivers, Growth and Opportunity Anal …
Global Matte Films Market business report is the all-inclusive market research report which studies the challenges, market structures, opportunities, driving forces, emerging trends, and competitive landscape of industry. The report encompasses primary, secondary and advanced information about the global market with respect to status, trends, size, share, growth, and segments in the forecasted period. This Industry report conducts thorough competitive research to provide better market insights. This market report
Alcohol Ingredients Market Size, Share, Trends, Demand, Growth and Competitive Analysis
Alcohol Ingredients Market Size, Share, Trends, Demand, Growth and Competitive A …
Data Bridge Market research has recently published the comprehensive business research on Global Alcohol Ingredients Market includes historic data, present market trends, future product environment, marketing strategies, technological innovation, upcoming technologies, emerging trends or opportunities, and the technical progress in the related industry. Alcohol Ingredients Market analysis report covers detailed value chain analysis of the market. Alcohol Ingredients Market business report provides exact information about market trends, industrial changes, and consumer
Dark Fiber Casting Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Dark Fiber Casting Market Size, Share, Trends, Key Drivers, Growth and Opportuni …
Dark Fiber Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. A detailed market research study of this report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion